Search

Filters
Types

Sign up for our free
equity research notes

Register
257 Results for ‘international biotechnology’
Embed
RIT Capital Partners – A rare opportunity to buy a unique trust?

RIT Capital Partners Investment companies | Initiation | 6 April 2023 A rare opportunity to buy a unique trust? Last year was a turbulent one for markets and, unusually, there were few places to hide, with nearly all asset classes recording large declines. RIT’s NAV also fell in 2022. Its managers comment that this appears […]

230406 rit
RIT Capital Partners – A rare opportunity to buy a unique trust

RIT Capital Partners Investment companies | Initiation | 6 April 2023 A rare opportunity to buy a unique trust Last year was a turbulent one for markets and, unusually, there were few places for investors to hide, with nearly all asset classes recording large declines. RIT’s net asset value (NAV) also fell in 2022, and […]

230406 rit
RIT Capital Partners – A rare opportunity to buy a unique trust

RIT Capital Partners Investment companies | Initiation | 6 April 2023 A rare opportunity to buy a unique trust Last year was a turbulent one for markets and, unusually, there were few places to hide, with nearly all asset classes recording large declines. RIT’s NAV also fell in 2022 and this appears to have unnerved […]

230406 rit
QuotedData’s Economic and Political Monthly Roundup April 2023

Economic and Political Monthly Roundup Investment companies | Monthly | April 2023 A collation of recent insights on markets and economies taken from the comments made by chairs and investment managers of investment companies – have a read and make your own minds up. Please remember that nothing in this note is designed to encourage […]

Storm,Clouds,Saskatchewan,Wind,Farm,Swift,Current,Canada
QuotedData’s Investment Companies Annual Review – 2022

Review 2022 Annual roundup | Investment companies | January 2023 Kindly sponsored by abrdn A year to forget? Any optimism that investors felt going into 2022 was dashed in February with Russia’s invasion of Ukraine. Resultant jumps in energy and food prices helped entrench inflation, requiring more aggressive interest rate hikes from central banks. Investments […]

230123 a year to forget ukraine
Conviction Life Sciences Company – CLSC Initial Public Offering – update

CLSC Initial Public Offering Investment companies | IPO note – update | 17 January 2023 Conviction Life Sciences Company (CLSC) has a target issuance of up to 100m ordinary shares at 100p per share as part of the company’s initial issue, equal to an initial market cap of up to £100m. CLSC is being launched […]

221118 CLSC
Conviction Life Sciences Company – CLSC Initial Public Offering – update

  CLSC Initial Public Offering Investment companies | IPO note – update | 17 January 2023 Conviction Life Sciences Company (CLSC) has a target issuance of up to 100m ordinary shares at 100p per share as part of the company’s initial issue, equal to an initial market cap of up to £100m. CLSC is being […]

221118 CLSC
QuotedData’s Economic and Political Monthly Roundup January 2023

Economic and Political Monthly Roundup Investment companies | Monthly | January 2023 A collation of recent insights on markets and economies taken from the comments made by chairs and investment managers of investment companies – have a read and make your own minds up. Please remember that nothing in this note is designed to encourage […]

Apr-23-2022,Press,Conference,Of,Volodymyr,Zelenskyy,The,President,Of,Ukraine
Conviction Life Sciences Company – CLSC Initial Public Offering

CLSC Initial Public Offering Investment companies | IPO note | 22 November 2022 Conviction Life Sciences Company (CLSC) has a target issuance of up to 100m ordinary shares at 100p per share as part of the company’s initial issue, equal to an initial market cap of up to £100m. CLSC is being launched to capitalise […]

221118 CLSC
Conviction Life Sciences Company – CLSC Initial Public Offering

CLSC Initial Public Offering Investment companies | IPO note | 22 November 2022 Conviction Life Sciences Company (CLSC) has a target issuance of up to 100m ordinary shares at 100p per share as part of the company’s initial issue, equal to an initial market cap of up to £100m. CLSC is being launched to capitalise […]

221118 CLSC